MediGene

SpectraScience Adds Industry Veteran to Executive Team

...e appointment of its new Vice President of Sales, Christopher Jackson, who has held senior sales positions at Adeza Biomedical Specialty Laboratories, medigene and most recently at Neomatrix, Inc. "Chris brings to SpectraScience more than 24 years of sales and marketing experience in the medical device and ...

Eligard(R) six-month formulation successfully completes European approval procedure

...me of the appeal in German patent litigation commenced by Takeda Chemical Industries Ltd. and Wako Pure Chemical Industries, Ltd. against Astellas and medigene in Germany with respect to Eligard may be unfavorable and could result in QLT USA, Inc. being required to pay financial damages which could be substan...

MediGene in Medical Technology

European Society for Medical Oncology (ESMO) Presents Data from the Clinical Trial of MediGene's Cancer-Killing Virus in Press Conference

...ading cancer centers in the US. In September 2006, medigene announced positive safety and efficacy data from a...tements contained herein represent the judgment of medigene as of the date of this release. These forward-look...nts discussed in this press release may not occur. medigene disclaims any intent or obligation to update any o...

MediGene in Biological Technology

New Report Just Published: World Prostate Cancer Therapeutics Market Report

... AbbeyMoor Collaborate to Develop Products to Treat Prostate Diseases II-84 Dendreon Constructs Manufacturing Facility in New Jersey II-84 medigene Introduces Prostate Cancer Drug in Italian Market II-85 Gen-Probe Introduces Innovative Test for Prostate Cancer in Europe II-85 DRL Intro...

Mergent, Inc. Announces Quarterly Rebalancing of HealthShares(TM) Indexes

... (NASDAQ: BTRX ) INNOGENETICS NV (Euronext, Brussels: INNX) INTEGRA LIFESCIENCES HOLDINGS CORP (NASDAQ: IART ) KV PHARMACEUTICAL CO (NYSE: KV/A) medigene AG (Frankfurt, Germany: MDG) MENTOR CORP (NYSE: MNT ) MYLAN INC. (NYSE: MYL ) NUSKIN ENTERPRISES INC. (NYSE: NUS ) OMEGA PHARMA SA (Euronext, B...

Bradley Pharmaceuticals Launches Veregen(TM) (sinecatechins) Ointment, 15%

...nts 18 years and older. Veregen(TM) is the first new prescription treatment for external genital warts in ten years. Bradley licensed the product from medigene AG (Frankfurt: MDG) and has exclusive marketing rights in the United States. Veregen(TM) is the first botanical drug approved for prescription use i...